2023
Treatment of Stiff-Person Syndrome with Botulinum Toxin
Safarpour D, Jabbari B. Treatment of Stiff-Person Syndrome with Botulinum Toxin. 2023, 174-179. DOI: 10.1017/9781009105033.021.Peer-Reviewed Original ResearchBotulinum toxinStiff-person syndromeBotulinum toxin therapyToxin therapyToxin formulationsBedside guidanceInjection siteCosmetic treatmentCadaveric dissectionAnatomical landmarksSmile correctionToxinTreatmentEyesInjectionClinician's eyeLower facePathophysiologySyndromeTherapyCliniciansPhysiciansDissectionTreatment of Plantar Fasciitis/Plantar Fasciopathy with Botulinum Neurotoxins
Safarpour D, Mittal S, Jabbari B. Treatment of Plantar Fasciitis/Plantar Fasciopathy with Botulinum Neurotoxins. 2023, 269-274. DOI: 10.1017/9781009105033.034.Peer-Reviewed Original ResearchBotulinum toxinBotulinum toxin therapyPlantar FasciopathyToxin therapyToxin formulationsBedside guidanceInjection siteCosmetic treatmentCadaveric dissectionAnatomical landmarksSmile correctionBotulinum neurotoxinToxinTreatmentEyesInjectionClinician's eyeLower facePathophysiologyTherapyCliniciansPhysiciansDissection
2013
Hyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins
Lakraj AA, Moghimi N, Jabbari B. Hyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins. Toxins 2013, 5: 821-840. PMID: 23612753, PMCID: PMC3705293, DOI: 10.3390/toxins5040821.Peer-Reviewed Original ResearchConceptsClass II studiesII studyAxillary hyperhidrosisPalmar hyperhidrosisComparator studiesBotulinum toxinClass IEvidence level BLevel of evidenceClass III studiesOral agentsIII studyClinical featuresTopical agentsComparable efficacyLong lasting effectInjection sessionsBlinded studyAmerican AcademyDrug efficacyClass IIHyperhidrosisEfficacyWorld literatureToxin
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply